A newly uncovered report has revealed that a Pfizer scientist warned the company about a potential link between Zoloft and birth defects.
The attorneys at Schmidt Kramer are well-informed of the link between birth defects and anti-depressants.
Contact our birth injury lawyers for a free review of your claim if your child was affected by your use of Zoloft.
In 2014, Francesca Kolitsopoulous, associate director at Pfizer’s Worldwide Safety Strategy unit’s epidemiology group, reviewed published studies that alleged an associate between Zoloft and certain birth defects.
Kolitsopoulous concluded that researchers had indeed found links between Zoloft and birth defects like septal heart defects and omphalocele, a birth defect of the abdominal wall. The associate director proposed changing the drug’s warning labels.
Kolitsopoulous’s report on the review of such studies mirrors reports for Pfizer safety monitors back in 1998. The sixteen year old report revealed there were 25 cases involving congenital abnormalities linked to the use of Zoloft by pregnant women.
Some birth defects linked to Zoloft include:
- Hypoplastic left heart syndrome
- Ventricular septal defects
- Atrial septal defects
- Coarctation of the aorta
Pfizer is currently facing 1,000 lawsuits from families whose newborns were born with a birth defect after the mother took Zoloft while pregnant. Although the company was successful in defending itself during the first trial in April 2015, this new report could change future outcomes.
Unfortunately, Pfizer officials continue to deny that the drug is dangerous despite a judge ordering the company to change the warning label after the April 2015 trial.
The birth injury lawyers at Schmidt Kramer are dedicated to fighting for the rights of the injured, especially when a child is put in danger as a result of a company’s negligence. If you or someone you love was affected by Zoloft while pregnant, you may be entitled to compensation.